FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W852871457> ?p ?o ?g. }

• W852871457 endingPage "13" @default.
• W852871457 startingPage "207" @default.
• W852871457 abstract "Homocyst(e)ine is reported to increase the binding of lipoprotein(a) [Lp(a)] to fibrin, which may increase the thrombogenic effects of Lp(a) in vivo. The aim of this study was to investigate whether there is a relationship between homocyst(e)ine and Lp(a) levels and vascular disease risk, and if the relationship depends on the apo(a) isoforms.A case-control study was performed in 91 Caucasian male subjects with vascular disease due to athersclerosis, and in 100 healthy age- and sex-matched control subjects.Both hyperhomocyst(e)inemia and elevated Lp(a) were significantly more prevalent in patients. Concordant elevated Lp(a) and hyperhomocyst(e)inemia were not associated with increased vascular disease risk (relative odds 2.96; 95% CI: 0.90-9.80), while hyperhomocyst(e)inemia in the absence of elevated Lp(a) was associated with increased vascular disease risk (relative odds 7.20; 95% CI: 2.37-21.91). Hyperhomocyst(e)inemia in individuals with high-molecular weight apo(a) isoforms [smaller apo(a) isoform > S3] was observed to be associated with increased vascular disease risk (relative odds 11.02; 95% CI: 3.54-34.30), while vascular disease risk in subjects with low-molecular weight apo(a) isoforms [smaller apo(a) isoform < S3] was not significantly increased, the relative odds being 1.92; 95% CI: 0.51-7.24.We conclude that hyperhomocyst(e)inemia is an important risk factor in individuals with high-molecular weight apo(a) isoforms." @default.
• W852871457 created "2016-06-24" @default.
• W852871457 creator A5002519689 @default.
• W852871457 creator A5016665711 @default.
• W852871457 creator A5018090718 @default.
• W852871457 creator A5076851753 @default.
• W852871457 date "2004-10-16" @default.
• W852871457 modified "2023-10-18" @default.
• W852871457 title "Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms." @default.
• W852871457 cites W124033503 @default.
• W852871457 cites W1516430535 @default.
• W852871457 cites W1964498019 @default.
• W852871457 cites W1966206590 @default.
• W852871457 cites W1968470393 @default.
• W852871457 cites W1975415315 @default.
• W852871457 cites W1976773568 @default.
• W852871457 cites W1982391794 @default.
• W852871457 cites W1983055162 @default.
• W852871457 cites W1983106906 @default.
• W852871457 cites W1984692718 @default.
• W852871457 cites W1989069669 @default.
• W852871457 cites W1991075411 @default.
• W852871457 cites W1993729215 @default.
• W852871457 cites W1997354164 @default.
• W852871457 cites W1998239323 @default.
• W852871457 cites W2002821858 @default.
• W852871457 cites W2006760737 @default.
• W852871457 cites W2010933740 @default.
• W852871457 cites W2018371791 @default.
• W852871457 cites W2021905629 @default.
• W852871457 cites W2034278018 @default.
• W852871457 cites W2042198850 @default.
• W852871457 cites W2044262901 @default.
• W852871457 cites W2046913628 @default.
• W852871457 cites W2046942331 @default.
• W852871457 cites W2052911190 @default.
• W852871457 cites W2053361508 @default.
• W852871457 cites W2058970608 @default.
• W852871457 cites W2060008696 @default.
• W852871457 cites W2061688860 @default.
• W852871457 cites W2069981227 @default.
• W852871457 cites W2073646360 @default.
• W852871457 cites W2081221345 @default.
• W852871457 cites W2084945118 @default.
• W852871457 cites W2085959182 @default.
• W852871457 cites W2087316197 @default.
• W852871457 cites W2088704651 @default.
• W852871457 cites W2089205356 @default.
• W852871457 cites W2092004637 @default.
• W852871457 cites W2094115555 @default.
• W852871457 cites W2094548662 @default.
• W852871457 cites W2100107641 @default.
• W852871457 cites W2103003312 @default.
• W852871457 cites W2114574471 @default.
• W852871457 cites W2129933603 @default.
• W852871457 cites W2130483103 @default.
• W852871457 cites W2135307086 @default.
• W852871457 cites W2136145860 @default.
• W852871457 cites W2150789613 @default.
• W852871457 cites W2152339970 @default.
• W852871457 cites W2155822995 @default.
• W852871457 cites W2160783111 @default.
• W852871457 cites W2167779923 @default.
• W852871457 cites W2328908108 @default.
• W852871457 cites W2398195379 @default.
• W852871457 cites W2399464812 @default.
• W852871457 cites W2414614904 @default.
• W852871457 cites W2418382063 @default.
• W852871457 cites W2582586629 @default.
• W852871457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15483732" @default.
• W852871457 hasPublicationYear "2004" @default.
• W852871457 type Work @default.
• W852871457 sameAs 852871457 @default.
• W852871457 citedByCount "1" @default.
• W852871457 crossrefType "journal-article" @default.
• W852871457 hasAuthorship W852871457A5002519689 @default.
• W852871457 hasAuthorship W852871457A5016665711 @default.
• W852871457 hasAuthorship W852871457A5018090718 @default.
• W852871457 hasAuthorship W852871457A5076851753 @default.
• W852871457 hasConcept C104317684 @default.
• W852871457 hasConcept C126322002 @default.
• W852871457 hasConcept C134018914 @default.
• W852871457 hasConcept C156957248 @default.
• W852871457 hasConcept C2776104379 @default.
• W852871457 hasConcept C2777466421 @default.
• W852871457 hasConcept C2778163477 @default.
• W852871457 hasConcept C44249647 @default.
• W852871457 hasConcept C50440223 @default.
• W852871457 hasConcept C53345823 @default.
• W852871457 hasConcept C55493867 @default.
• W852871457 hasConcept C62746215 @default.
• W852871457 hasConcept C71924100 @default.
• W852871457 hasConcept C82789193 @default.
• W852871457 hasConcept C86803240 @default.
• W852871457 hasConceptScore W852871457C104317684 @default.
• W852871457 hasConceptScore W852871457C126322002 @default.
• W852871457 hasConceptScore W852871457C134018914 @default.
• W852871457 hasConceptScore W852871457C156957248 @default.

• next